Skip to main content
Erschienen in: Journal of Artificial Organs 4/2014

01.12.2014 | Original Article

Comparison of neovascularization in dermal substitutes seeded with autologous fibroblasts or impregnated with bFGF applied to diabetic foot ulcers using laser Doppler imaging

verfasst von: Naoki Morimoto, Natsuko Kakudo, Priscilla Valentin Notodihardjo, Shigehiko Suzuki, Kenji Kusumoto

Erschienen in: Journal of Artificial Organs | Ausgabe 4/2014

Einloggen, um Zugang zu erhalten

Abstract

A bilayered artificial dermis (AD) composed of an upper silicone sheet and a lower collagen sponge has been widely applied for skin defects. After application, fibroblasts and capillaries infiltrate the AD and the collagen sponge is replaced by host dermal tissue within a few weeks. However, this delay and the high incidence of infection are concerns regarding the use of AD in the treatment of chronic ulcers. In this study, we compared the neovascularization of conventional AD seeded with autologous fibroblasts (cultured dermis: CD) and collagen/gelatin sponge (CGS), which is a novel artificial dermis capable of sustained release of basic fibroblast growth factor (bFGF) after application using laser Doppler imaging (LDI). CD (n = 5) and CGS impregnated with bFGF (n = 6) were applied to diabetic foot ulcers after debridement. Perfusion units (PUs) were measured just after, and 1, 2 and 3 weeks after application, and complete healing rates within 16 weeks were compared. No significant differences in PUs were seen 1, 2 and 3 weeks after application and in healing rates within 16 weeks between the two groups. This study suggested that CD and CGS treatments were effective, but there were no significant differences between them in the treatment of diabetic ulcers .
Literatur
1.
2.
Zurück zum Zitat Suzuki S, Matsuda K, Nishimura Y, et al. Review of acellular and cellular artificial skins. Tissue Eng. 1996;2:267–75.PubMedCrossRef Suzuki S, Matsuda K, Nishimura Y, et al. Review of acellular and cellular artificial skins. Tissue Eng. 1996;2:267–75.PubMedCrossRef
3.
Zurück zum Zitat Momoh AO, Lypka MA, Echo A, et al. Reconstruction of full-thickness calvarial defect: a role for artificial dermis. Ann Plast Surg. 2009;62:656–9.PubMedCrossRef Momoh AO, Lypka MA, Echo A, et al. Reconstruction of full-thickness calvarial defect: a role for artificial dermis. Ann Plast Surg. 2009;62:656–9.PubMedCrossRef
4.
Zurück zum Zitat Ito K, Ito S, Sekine M, et al. Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast Reconstr Surg. 2005;115:567–72.PubMedCrossRef Ito K, Ito S, Sekine M, et al. Reconstruction of the soft tissue of a deep diabetic foot wound with artificial dermis and recombinant basic fibroblast growth factor. Plast Reconstr Surg. 2005;115:567–72.PubMedCrossRef
5.
Zurück zum Zitat Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng. 2006;12:2407–24 (Review).PubMedCrossRef Ehrenreich M, Ruszczak Z. Update on tissue-engineered biological dressings. Tissue Eng. 2006;12:2407–24 (Review).PubMedCrossRef
6.
Zurück zum Zitat Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res. 2009;9:115.PubMedCentralPubMedCrossRef Langer A, Rogowski W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Serv Res. 2009;9:115.PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Uchi H, Igarashi A, Urabe K, Koga T, Nalayama J, Kawamori R, Tamaki K, Hirakata H, Ohura T, Furue M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009;19:461–8.PubMed Uchi H, Igarashi A, Urabe K, Koga T, Nalayama J, Kawamori R, Tamaki K, Hirakata H, Ohura T, Furue M. Clinical efficacy of basic fibroblast growth factor (bFGF) for diabetic ulcer. Eur J Dermatol. 2009;19:461–8.PubMed
8.
Zurück zum Zitat Morimoto N, Takemoto S, Kanda N, Ayvazyan A, Taira MT, Suzuki S. The utilization of animal product-free media and autologous serum in an autologous dermal substitute culture. J Surg Res. 2011;171:339–46.PubMedCrossRef Morimoto N, Takemoto S, Kanda N, Ayvazyan A, Taira MT, Suzuki S. The utilization of animal product-free media and autologous serum in an autologous dermal substitute culture. J Surg Res. 2011;171:339–46.PubMedCrossRef
9.
Zurück zum Zitat Morimoto N, Ito T, Takemoto S, Katakami M, Kanda N, Tada H, Tanaka S, Teramukai S, Kawai K, Nakamura Y, Kasai Y, Masayuki Y, Maekawa T, Shimizu A, Suzuki S. An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers. Int Wound J. 2014;11:183–9.PubMedCrossRef Morimoto N, Ito T, Takemoto S, Katakami M, Kanda N, Tada H, Tanaka S, Teramukai S, Kawai K, Nakamura Y, Kasai Y, Masayuki Y, Maekawa T, Shimizu A, Suzuki S. An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers. Int Wound J. 2014;11:183–9.PubMedCrossRef
10.
Zurück zum Zitat Takemoto S, Morimoto N, Kimura Y, Taira T, Kitagawa T, Tomihata K, Tabata Y, Suzuki S. Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF. Tissue Eng Part A. 2008;14:1629–38.PubMedCrossRef Takemoto S, Morimoto N, Kimura Y, Taira T, Kitagawa T, Tomihata K, Tabata Y, Suzuki S. Preparation of collagen/gelatin sponge scaffold for sustained release of bFGF. Tissue Eng Part A. 2008;14:1629–38.PubMedCrossRef
11.
Zurück zum Zitat Kanda N, Morimoto N, Ayvazyan AA, Takemoto S, Kawai K, Nakamura Y, Sakamoto Y, Taira T, Suzuki S. Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model. J Tissue Eng Regen Med. 2014;8:29–40.PubMedCrossRef Kanda N, Morimoto N, Ayvazyan AA, Takemoto S, Kawai K, Nakamura Y, Sakamoto Y, Taira T, Suzuki S. Evaluation of a novel collagen-gelatin scaffold for achieving the sustained release of basic fibroblast growth factor in a diabetic mouse model. J Tissue Eng Regen Med. 2014;8:29–40.PubMedCrossRef
12.
Zurück zum Zitat Morimoto N, Yoshimura K, Niimi M, Ito T, Aya R, Fujitaka J, Tada H, Teramukai S, Murayama T, Toyooka C, Miura K, Takemoto S, Kanda N, Kawai K, Yokode M, Shimizu A, Suzuki S. Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcers. Tissue Eng Part A. 2013;19:1931–40.PubMedCrossRef Morimoto N, Yoshimura K, Niimi M, Ito T, Aya R, Fujitaka J, Tada H, Teramukai S, Murayama T, Toyooka C, Miura K, Takemoto S, Kanda N, Kawai K, Yokode M, Shimizu A, Suzuki S. Novel collagen/gelatin scaffold with sustained release of basic fibroblast growth factor: clinical trial for chronic skin ulcers. Tissue Eng Part A. 2013;19:1931–40.PubMedCrossRef
13.
Zurück zum Zitat Morimoto N, Takemoto S, Kawai K, Aya R, Ishisaka T, Suzuki S. Immediate evaluation of neovascularization in a grafted bilayered artificial dermis using laser Doppler imaging. Ann Plast Surg. 2014;72:84–8.PubMedCrossRef Morimoto N, Takemoto S, Kawai K, Aya R, Ishisaka T, Suzuki S. Immediate evaluation of neovascularization in a grafted bilayered artificial dermis using laser Doppler imaging. Ann Plast Surg. 2014;72:84–8.PubMedCrossRef
14.
Zurück zum Zitat Monstrey SM, Hoeksema H, Baker RD, et al. Burn wound healing time assessed by laser Doppler imaging. Part 2: validation of a dedicated colour code for image interpretation. Burns. 2011;37:249–56.PubMedCrossRef Monstrey SM, Hoeksema H, Baker RD, et al. Burn wound healing time assessed by laser Doppler imaging. Part 2: validation of a dedicated colour code for image interpretation. Burns. 2011;37:249–56.PubMedCrossRef
15.
Zurück zum Zitat Riordan CL, McDonough M, Davidson JM, et al. Noncontact laser Doppler imaging in burn depth analysis of the extremities. J Burn Care Rehabil. 2003;24:177–86.PubMedCrossRef Riordan CL, McDonough M, Davidson JM, et al. Noncontact laser Doppler imaging in burn depth analysis of the extremities. J Burn Care Rehabil. 2003;24:177–86.PubMedCrossRef
16.
Zurück zum Zitat Vuorisalo S, Venermo M, Lepäntalo M. Treatment of diabetic foot ulcers. J Cardiovasc Surg. 2009;50:275–91 (Review). Vuorisalo S, Venermo M, Lepäntalo M. Treatment of diabetic foot ulcers. J Cardiovasc Surg. 2009;50:275–91 (Review).
17.
Zurück zum Zitat Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.PubMedCrossRef Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005;293:217–28.PubMedCrossRef
18.
Zurück zum Zitat Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26:1701–5.PubMedCrossRef Marston WA, Hanft J, Norwood P, Pollak R. The efficacy and safety of Dermagraft in improving the healing of chronic diabetic foot ulcers: results of a prospective randomized trial. Diabetes Care. 2003;26:1701–5.PubMedCrossRef
19.
Zurück zum Zitat Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O’Connell SM, Steinberg J, Falanga V. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen. 2006;14:102–9 (Review).PubMedCrossRef Cavorsi J, Vicari F, Wirthlin DJ, Ennis W, Kirsner R, O’Connell SM, Steinberg J, Falanga V. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers. Wound Repair Regen. 2006;14:102–9 (Review).PubMedCrossRef
20.
Zurück zum Zitat Tuyet HL, Quynh TTN, Minh HVH, Bich DNT, Dinh TD, Tan DL, Van HL, Huy TL, Huu HD, Trong TNT. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results. Int Wound J. 2009;6:159–66.PubMedCrossRef Tuyet HL, Quynh TTN, Minh HVH, Bich DNT, Dinh TD, Tan DL, Van HL, Huy TL, Huu HD, Trong TNT. The efficacy and safety of epidermal growth factor in treatment of diabetic foot ulcers: the preliminary results. Int Wound J. 2009;6:159–66.PubMedCrossRef
21.
Zurück zum Zitat Senet P, Vicaut E, Beneton N, Debure C, Lok C, Chosidow O. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Arch Dermatol. 2011;147:926–30.PubMedCrossRef Senet P, Vicaut E, Beneton N, Debure C, Lok C, Chosidow O. Topical treatment of hypertensive leg ulcers with platelet-derived growth factor-BB: a randomized controlled trial. Arch Dermatol. 2011;147:926–30.PubMedCrossRef
22.
Zurück zum Zitat Yamada N, Uchinuma E, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. J Artif Organs. 2008;11:100–3.PubMedCrossRef Yamada N, Uchinuma E, Kuroyanagi Y. Clinical trial of allogeneic cultured dermal substitutes for intractable skin ulcers of the lower leg. J Artif Organs. 2008;11:100–3.PubMedCrossRef
23.
Zurück zum Zitat Dinh TL, Veves A. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg. 2006;117:152S–7S (Review).PubMedCrossRef Dinh TL, Veves A. The efficacy of Apligraf in the treatment of diabetic foot ulcers. Plast Reconstr Surg. 2006;117:152S–7S (Review).PubMedCrossRef
Metadaten
Titel
Comparison of neovascularization in dermal substitutes seeded with autologous fibroblasts or impregnated with bFGF applied to diabetic foot ulcers using laser Doppler imaging
verfasst von
Naoki Morimoto
Natsuko Kakudo
Priscilla Valentin Notodihardjo
Shigehiko Suzuki
Kenji Kusumoto
Publikationsdatum
01.12.2014
Verlag
Springer Japan
Erschienen in
Journal of Artificial Organs / Ausgabe 4/2014
Print ISSN: 1434-7229
Elektronische ISSN: 1619-0904
DOI
https://doi.org/10.1007/s10047-014-0782-0

Weitere Artikel der Ausgabe 4/2014

Journal of Artificial Organs 4/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.